Avantor, Inc. (NYSE:AVTR) Given Consensus Recommendation of “Reduce” by Analysts

Shares of Avantor, Inc. (NYSE:AVTR) have been given an average recommendation of “Reduce” by the seventeen brokerages that are presently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have assigned a buy rating to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $10.6250.

A number of research firms recently commented on AVTR. TD Cowen reissued a “hold” rating on shares of Avantor in a research report on Wednesday, July 15th. Barclays lifted their price objective on shares of Avantor from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, June 24th. UBS Group set a $8.00 target price on shares of Avantor in a research note on Wednesday, June 24th. Evercore set a $10.50 target price on shares of Avantor in a report on Monday, July 6th. Finally, Wall Street Zen raised shares of Avantor from a “hold” rating to a “buy” rating in a research report on Saturday, June 27th.

Insider Transactions at Avantor

In other news, Director Gregory T. Lucier acquired 10,000 shares of the firm’s stock in a transaction on Friday, May 8th. The stock was purchased at an average price of $8.32 per share, for a total transaction of $83,200.00. Following the purchase, the director owned 60,000 shares in the company, valued at approximately $499,200. This represents a 20.00% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Simon Dingemans bought 25,000 shares of the company’s stock in a transaction on Friday, May 1st. The shares were purchased at an average cost of $8.14 per share, for a total transaction of $203,500.00. Following the transaction, the director owned 25,000 shares in the company, valued at approximately $203,500. This represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.28% of the company’s stock.

Institutional Trading of Avantor

A number of hedge funds have recently bought and sold shares of the business. Private Management Group Inc. increased its position in Avantor by 50.4% in the fourth quarter. Private Management Group Inc. now owns 2,456,859 shares of the company’s stock worth $28,156,000 after buying an additional 823,572 shares during the last quarter. Brickwood Asset Management LLP raised its stake in shares of Avantor by 6,891.9% in the fourth quarter. Brickwood Asset Management LLP now owns 3,184,043 shares of the company’s stock valued at $36,489,000 after buying an additional 3,138,504 shares during the period. Assenagon Asset Management S.A. purchased a new position in shares of Avantor during the 4th quarter valued at $41,490,000. SG Americas Securities LLC lifted its position in shares of Avantor by 209.5% during the 4th quarter. SG Americas Securities LLC now owns 401,969 shares of the company’s stock valued at $4,607,000 after buying an additional 272,093 shares during the last quarter. Finally, Agman Capital LLC bought a new position in shares of Avantor during the 4th quarter worth $3,915,000. 95.08% of the stock is currently owned by institutional investors.

Avantor Stock Performance

Shares of Avantor stock opened at $11.34 on Friday. The company has a market cap of $7.74 billion, a PE ratio of -13.99, a price-to-earnings-growth ratio of 6.10 and a beta of 0.94. Avantor has a 52 week low of $7.26 and a 52 week high of $15.93. The business has a 50 day moving average price of $9.64 and a 200-day moving average price of $9.40. The company has a quick ratio of 1.17, a current ratio of 1.76 and a debt-to-equity ratio of 0.68.

Avantor (NYSE:AVTR) last announced its earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.01. The company had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.Avantor’s quarterly revenue was up .0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.23 earnings per share. Equities analysts anticipate that Avantor will post 0.79 earnings per share for the current fiscal year.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.